Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study

Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study

Abstract Background Interstitial lung disease (ILD) related to rheumatoid arthritis (RA) is among the leading causes of death and an essential prognostic factor. There is only limited evidence for the safety of anti-rheumatic drugs for patients with RA-ILD. The aim of this study is to investigate th...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Atsuko Tsujii, Kentaro Isoda, Maiko Yoshimura, Akihiko Nakabayashi, Dong-Seop Kim, Tatsuya Tamada, Kurumi Yamamoto, Shiro Ohshima
Format: Article
Sprog:English
Udgivet: BMC 2024-01-01
Serier:BMC Rheumatology
Fag:
CTLA-4-Ig
Interstitial lung diseases
Janus kinase inhibitors
Retrospective study
Rheumatoid arthritis
Rheumatoid arthritis-associated interstitial lung disease
Online adgang:https://doi.org/10.1186/s41927-024-00374-x

Internet

https://doi.org/10.1186/s41927-024-00374-x

Lignende værker